Plaque psoriasis
Adult: Initially, 160 mg once, then followed by 80 mg once every 2 weeks for 6 doses (at weeks 2, 4, 6, 8, 10 and 12). Maintenance: 80 mg every 4 weeks. Consider treatment discontinuation if there is no response after 16-20 weeks.
Subcutaneous
Psoriatic arthritis
Adult: Patient who are intolerant to previous disease-modifying antirheumatic drugs (DMARDs) therapy: As monotherapy or in combination with a DMARD (e.g. methotrexate): Initially, 160 mg once, then followed by 80 mg every 4 weeks. Consider treatment discontinuation if there is no response after 16-20 weeks. Patient with concomitant moderate to severe plaque psoriasis, follow dosing guidelines for plaque psoriasis.